Abstract
Kaposi's sarcoma, a virus-associated neoplasm, can be treated with systemic therapy such interferon or chemotherapy, although a local alternative is possible in localized disease. Topical imiquimod is a ligand of the toll-like receptors 7 and 8 on dendritic cells, increasing immune responses and showing antiviral and antitumoral activities. We report a spectacular response to imiquimod 5% cream in a patient with classic Kaposi's sarcoma of the leg. © 2009 Benomar et al.; licensee Cases Network Ltd.
Cite
CITATION STYLE
Benomar, S., Boutayeb, S., Benzekri, L., Errihani, H., & Hassam, B. (2009). Kaposi’s sarcoma responding to topical imiquimod 5% cream: A case report. Cases Journal, 2(9). https://doi.org/10.4076/1757-1626-2-7092
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.